Digital Medicine
PhysIQ Announces Strategic Collaboration to Scale Digital Medicine
physIQ
PR-M04-21-019Apr 20, 2021
Multiple Myeloma
Janssen Reports Positive Results for DARZALEX® in Multiple Myeloma
Emilie Branch
Pharma's Almanac
PAO-M12-19-NI-006Dec 13, 2019
FDA Approval
Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Janssen Pharmaceutical Companies
PR-M10-19-NI-032-2050Oct 22, 2019
Strategic Partnership
nference Enters into an R&D Data Science Strategic Partnership with Janssen
nference
PR-M06-19-NI-013Jun 13, 2019
Drug Design
Janssen, Iktos Collaborate on In Silico Drug Design
Emilie Branch
Pharma's Almanac
PAO-M05-19-NI-022May 21, 2019
FDA
Janssen Aims for Supplemental U.S. FDA Approval for INVOKANA®
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-007Apr 02, 2019
New Drug Application
Janssen Submits Supplemental New Drug Application to U.S. FDA for INVOKANA® (canagliflozin) for the Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes
Janssen Pharmaceutical Companies
PR-M04-19-NI-008Apr 02, 2019
HIV
Long-Acting Injectable HIV Treatment Regimen of Rilpivirine and Cabotegravir Demonstrated Comparable Safety and Efficacy to Daily Oral HIV Therapy
Johnson & Johnson
PR-M03-19-NI-033Mar 12, 2019
Approval
Xarelto Gets Approval for Additional Indication
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M10-18-NI-019Oct 22, 2018